Related by context. Frequent words. (Click for all words.) 61 Inc. NYSE ZMH 58 Corp. SYK 56 Company Nasdaq PRGO 56 NYSE PFE 55 NYSE GDT 55 Medtronic Sofamor Danek 55 Terumo Corporation 55 PROFILE CO 54 Nasdaq VRTX 54 Zimmer Holdings 54 CareFusion Corporation 54 SYK 54 AGA Medical Holdings 54 Calls Purchased 53 Bearish Pressure Building 53 Sirona Dental Systems 53 Medtronic MDT 53 Covidien plc 53 AUXL 53 Integra LifeSciences 52 Alphatec Holdings Inc. 52 NASDAQ CRXL 52 Looks Bullish 52 Kensey Nash Corporation 51 Synovis Life Technologies 51 Integra LifeSciences Holdings 51 Declares Quarterly Dividends 51 NYSE SNN 51 DENTSPLY International 51 Merge Technologies 51 AMAG Pharmaceuticals 51 CR Bard 51 Co MRK 51 BioMimetic Therapeutics Inc. 51 F#Q# Qtr End 50 Medtronics 50 Stock Downgraded 50 TSX ANP 50 orthopedic implant 50 VPHM 50 Symmetry Medical Inc. 50 Director Exercises Options 50 Schering Plough NYSE SGP 50 Covidien Ltd. 50 HEICO Corporation 50 Inc Therapeutic Competitors 50 CEO Exercises Options 50 Jon Kamp 50 NYSE BSX 50 Abbott Laboratories ABT 50 VNUS Medical Technologies 50 Boston Scientific BSX 50 Talecris Biotherapeutics Holdings 50 Declares Regular Quarterly 50 WMGI 50 NYSE MYL 49 BioSphere Medical Inc. 49 Tissue Repair Company 49 Johnson NYSE JNJ 49 Chronimed 49 Medical STJ 49 PRGO 49 LTX Credence Corporation 49 DePuy Spine 49 Johnson JNJ 49 Orthofix International 49 Quest Diagnostics Inc 49 ICOS Corporation 49 LeMaitre Vascular 49 ALNY 49 Biomet 49 Idera Pharmaceuticals 49 Dentsply International 49 Allergan Inc 49 NYSE OMI 49 WCRX 48 Cougar Biotechnology Inc. 48 BioMimetic Therapeutics 48 Hill Rom Holdings 48 McKesson NYSE MCK 48 Somanetics Corporation 48 Stanley Works SWK 48 ZMH 48 CRXX 48 Allscripts Healthcare Solutions 48 Completes Tender Offer 48 Cephalon CEPH 48 CTI Molecular Imaging 48 Dade Behring Holdings 48 CYBX 48 Aastrom Biosciences 48 CR Bard Inc. 48 Allergan AGN 48 Anika Therapeutics 48 SWOT Analysis companiesandmarkets.com adds 48 Lowers Guidance 48 Co. NYSE MRK 48 Abbott ABT 48 AMMD 48 CLDA 48 Q2 Loss Narrows